Abstract
This is an experimental study on the distribution of antituberculosis drugs such as rifampin, isoniazid, and pyrazinamide in pathologic vertebrae of spinal tuberculosis in order to provide the regimen of chemotherapy and surgical treatment of spinal tuberculosis. The distribution of antituberculosis drugs in pathologic vertebral tissues matters greatly to the clinical effect of spinal tuberculosis’ treatment. However, few pharmacokinetic studies and clinical reports about the concentrations of antituberculosis drugs in vertebral foci have been published so far. Twenty-four patients with spinal tuberculosis were divided into sclerotic group (n = 15) or non-sclerotic group (n = 9) according to radiographic features of lesion. All patients received chemotherapy with 2HRZ/2·5H2R2Z2 for a duration of 4.5 months. Four weeks after chemotherapy all patients underwent surgery and the specimen of serum, ilium, and pathologic vertebral tissues, including sclerotic wall, subnormal osseous tissue, and foci were obtained during operation in 120–130 and 180–190 min after oral intake in the morning, respectively. The levels of three drugs in the specimen were measured using HPLC method. The concentration levels of isoniazid, rifampin and pyrazinamide varied greatly in different tissues of spinal tuberculosis, of which the bactericidal concentration values of isoniazid and rifampin and fivefold minimal inhibitory concentration (MICs) of pyrazinamide were found in subnormal vertebral bone and self-contrast ilium, the MICs of all drugs were found in sclerotic wall outside foci, and undetected level was found in foci inside the sclerotic wall. To patients without vertebral sclerotic wall around the foci, the isoniazid in foci was of bactericidal level and rifampin and pyrazinamide in foci corresponded to the MICs respectively. The sclerotic bone of affected vertebra plays an important role in blocking the antituberculosis drug’s penetration into tuberculosis focus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Both B (1984) Penetration of parenterally administered rifampicin into bone tissue. Chemotherapy 30:358–365
Coordination Group of the State Short-Course Chemotherapy for Pulmonary Tuberculosis (1998) Clinical comparison studies on a 5 month chemotherapy and 6 month whole course intermittent program in the treatment of pulmonary tuberculosis with positive bacteria. Chin J Tuberc Respir 21:388–391
Deng L, Jiang X, Chen J et al (2003) Study on pharmacokinetics and bioequivalent evaluation of Yif uxianan tablets. Chin Hosp Pharm J 23:475–478
Dept of Orthopedics (1974) Tianjin Hospital, Clinical Osteology (II). Tuberculosis, 1st edn. People’s Health Publishing House, Beijing, p. 215
Ge Z, Wang Z, Wei M (2004) An experimental study of rifampicin’s distribution in different tissues of spinal tuberculosis patients. Chin J Spine Spinal Cord 14:741–744
Jain R, Sawhney S, Berry M (1993) Computed tomography of vertebral tuberculosis: patterns of bone destruction. Clin Radiol 47:196–199
Lee J (1997) Clinical pharmacology, 2 edn. People’s Health Publishing House, Beijing, pp 692–700
Li P, Yang W, Zhong Q (2003) Computed tomography of vertebral tuberculosis. CT Theory 7 Appl 13:33–35
Liu H, Wang J, Hou J et al (2000) Pharmacokinetics of rifampin in healthy volunteers after a high oral dose. Chin J Pharm 35:396–398
Panchagnula R, Sood A, Sharda N et al (1999) Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method. J Pharm Biomed Anal 18:1013–1020. doi:10.1016/S0731-7085(98)00112-5
Roncoroni AJ, Manuel C, Nedjar C et al (1981) Cefamandole bone diffusion in patients undergoing total hip replacement. Chemotherapy 27:166–172
Tuli SM, Kumar K, Sen PC (1977) Penetration of antituberculosis drugs in clinical osteoarticular tubercular lesion. Acta Orthop Scand 48:362–368
Wang Z, Ge Z, Jin W et al (2007) Treatment of spinal tuberculosis with ultrashort-course chemotherapy in conjunction with partial excision of pathologic vertebrae. Spine J 7:671–681. doi:10.1016/j.spinee.2006.07.016
Wang Z, Yang W, Jin W et al (2004) Treatment of spinal tuberculosis with anterior partial vertebrectomy, iliac grafting and internal fixation. Chin J Spine Spinal Cord 14:716–719
Wu Q, Duan L, Ling Y et al (1998) Comparison of three antituberculous drugs in serum and cold abscessed of patients with spinal tuberculosis. Chin J Tuberc Respir 21:617–619
Yang W, Wang Z, Qiao Y et al (2006) Resectable range of anterior partial vertebrectomy for spinal tuberculosis. J Fourth Mil Med Univ 27:695–697
Zhuo H, Lei Y, Wang C et al (1999) Study of pharmacokinetic and bioavailability of a combination rifampicin tablet in healthy volunteers. Chin J Clin Pharm 15:425–430
Acknowledgments
This work was supported in part by grants from a grant from Ningxia Science Foundation, People’s Republic of China. The technical assistance of Dr. Wei Minji is greatly appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ge, Z., Wang, Z. & Wei, M. Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis. Eur Spine J 17, 1482–1487 (2008). https://doi.org/10.1007/s00586-008-0778-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00586-008-0778-7